Biomanufacturing Media
-
Bioprocessing Solutions For Cell Culture
6/16/2025
Whatever the scope of your project, you can choose from our unmatched portfolio of high-impact produCTS and services to deliver consistent, scalable solutions.
-
Perfusion: Planning A Run
6/16/2025
Learn about a logical approach for defining the operation of a perfusion run. We will break down the process using the three following steps: knowledge space, design space, and control space.
-
BPI Interviews Purification And Pharma Analytics Leader
6/9/2025
Jean Luo, VP of Purification and Pharma Analytics, discusses innovations in bioprocessing, including the development of dPCR assays, lentiviral titer systems, chromatography resins, and supply chain.
-
Optimize Your Advanced Therapy Manufacturing Process Before You Automate
6/5/2025
Dive into specific unit operations and case studies that demonstrate how implementing phase appropriate tools can have substantive direct business impacts to cost and development timelines.
-
Driving The Expansion Of mRNA Into The Therapeutic Sphere
6/5/2025
Discover the next wave of mRNA therapeutics and how emerging technologies are solving key challenges in downstream processing and analysis to enhance both safety and efficacy.
-
Simplify CAR-T Cell Manufacturing With LNP-Mediated Delivery
6/3/2025
Streamline CAR-T cell manufacturing with lipid nanoparticles delivering base editors to create fratricide-resistant, CD45-edited CAR45 T cells, which enables scalable, precise, and potent therapies for blood cancers.
-
A New Look At Subcutaneous mAb Delivery Using Nanoformed Particles
6/3/2025
A highly concentrated non-aqueous suspension of an IgG1 was developed using a patented platform. Review how the particle size of the mAb impacts the overall behavior of the drug product.
-
Characterizing Product- And Process-Related Impurities In Multispecifics
6/2/2025
In this segment from the Bioprocess Online Live event, “Challenges And Considerations For Purifying Multispecific Molecules,” our panelists Mark Fitchmun and Dr. Jian Ren examine the types of common impurities manufacturers encounter in multispecific purification and explain the differences between product-related impurities and process-related impurities.
-
Involve CMC And Formulations Experts Early In Process Development
6/2/2025
In this segment from the Bioprocess Online Live event, “Challenges And Considerations For Purifying Multispecific Molecules,” our panelists talk about the cross-functional importance of formulations and CMC leads in process development.
-
How To Successfully Control The Upscaling Of Your LNP Formulation
5/28/2025
Discover key strategies for controlling LNP formulation and upscaling. Explore the science behind lipid nanoparticles, critical parameters, and achieving effective turbulent mixing for optimal outcomes.